Conversion of atrial fibrillation with antazoline hydrochloride (Arithmin)

Angiology. 1970 Jan;21(1):11-7. doi: 10.1177/000331977002100104.

D A Gehring, J G Kehler

PMID: 5415197 DOI: 10.1177/000331977002100104

Products

Cat. No.

Product Name

Description

Target

Research Area
HY-B1067

Antazoline hydrochloride

99.70%, Histamine Receptor Inhibitor

Histamine Receptor; HBV

Neurological Disease; Endocrinology
HY-B1067A

Antazoline

99.70%, H1 Receptor Antagonist

Histamine Receptor

Neurological Disease; Endocrinology
HY-B1067B

Antazoline phosphate

H1 Receptor Antagonist

Histamine Receptor

Neurological Disease; Endocrinology
HY-B1067R

Antazoline hydrochloride (Standard)

Histamine Receptor Inhibitor

Reference Standards; Histamine Receptor; HBV

Neurological Disease; Endocrinology
HY-B1067BR

Antazoline phosphate (Standard)

H1 Receptor Antagonist

Reference Standards; Histamine Receptor

Neurological Disease; Endocrinology
HY-B1067AR

Antazoline (Standard)

H1 Receptor Antagonist

Reference Standards; Histamine Receptor

Neurological Disease; Endocrinology

MedChemExpress Magic Cece

MedChemExpress: Contact Us; About Us; Headquarters; Distributors; Statement on False Report; Careers

Customer Support: Technical Support; Service; Ordering Information; Easy Return; Shipping Rates & Policies; Intellectual Property Promise

Resources: Free Sample; Resources; Molarity Calculator; Dilution Calculator; Terms & Conditions; Reconstitution Calculator; Specific Activity Calculator; DNA/RNA sequence conversion tools

Subscribe to our E-newsletter

Name
Email *

	Sorry, but the email address you supplied was invalid.

Products are chemical reagents for research use only and are not intended for human use. We do not sell to patients.

Copyright © 2013-2025 MedChemExpress. All Rights Reserved.: Site Map Privacy Policy

Join with us